Stock Events

Stock Events

Merrimack Pharmaceuticals (MACK) Q4 2022 Earnings

Mar 9Confirmed

May 2022

Aug 2022

Nov 2022

Q4 2022

-0.67

-0.46

-0.24

-0.03

Details

Expected EPS

N/A

Actual EPS

-0.03

Surprise EPS

N/A

Surprise Percent

N/A

Description

⁨Merrimack Pharmaceuticals⁩ (⁦MACK⁩) has reported earnings of ⁦-0.03⁩ per share for ⁦Q4 2022⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.